Moberg Pharma AB (publ)
SSE:MOB.ST
15.1 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SEK.
| 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0.207 | 0 | 33.659 | 439.041 | 439.032 | 334.304 | 285.566 | 200.18 | 157.389 | 112.469 | 55.943 | 8.512 | 1.616 | 0 |
| Kosten van de omzet
| 2.099 | 2.582 | 2.584 | 0 | 104.436 | 125.179 | 101.355 | 71.92 | 49.064 | 39.967 | 24.877 | 16.63 | 2.849 | 0 | 0 |
| Brutowinst
| -2.099 | -2.375 | -2.584 | 33.659 | 334.605 | 313.853 | 232.949 | 213.646 | 151.116 | 117.422 | 87.592 | 39.313 | 5.663 | 1.616 | 0 |
| Brutowinstmarge
| 0 | -11.473 | 0 | 1 | 0.762 | 0.715 | 0.697 | 0.748 | 0.755 | 0.746 | 0.779 | 0.703 | 0.665 | 1 | 0 |
| Onderzoek- en ontwikkelingskosten
| 3.657 | 21.234 | 21.887 | 24 | 58.331 | 49.025 | 42.732 | 48.897 | 46.483 | 56.871 | 54.232 | 26.808 | 18.992 | 15.706 | 26.186 |
| Algemene en administratieve kosten
| 21.603 | 20.057 | 18.438 | 20.354 | 41.01 | 34.614 | 30.29 | 25.642 | 26.553 | 27.832 | 23.45 | 23.256 | 19.551 | 10.298 | 10.625 |
| Verkoop- en marketingkosten
| 3.257 | 1.014 | 0.07 | 0.179 | 226.962 | 226.573 | 170.833 | 123.47 | 85.998 | 69.774 | 21.977 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 24.86 | 1.014 | 0.07 | 0.179 | 226.962 | 226.573 | 170.833 | 123.47 | 85.998 | 69.774 | 21.977 | 23.256 | 19.551 | 10.298 | 10.625 |
| Overige kosten
| -1.054 | -1.524 | -2.436 | -2.495 | -5.452 | 0.991 | 4.219 | 11.601 | 6.671 | 5.066 | -0.104 | -3.153 | -2.762 | -0.112 | -0.109 |
| Bedrijfskosten
| 27.463 | 20.724 | 19.521 | 21.684 | 279.841 | 276.589 | 217.784 | 183.968 | 139.152 | 131.711 | 76.105 | 46.911 | 35.781 | 25.893 | 36.701 |
| Bedrijfsresultaat
| -27.463 | -20.517 | -19.73 | -21.684 | 64.819 | 51.075 | 62.172 | 35.184 | 17.227 | -14.055 | 12.594 | -7.598 | -30.119 | -24.276 | -36.701 |
| Bedrijfsresultaat ratio
| 0 | -99.116 | 0 | -0.644 | 0.148 | 0.116 | 0.186 | 0.123 | 0.086 | -0.089 | 0.112 | -0.136 | -3.538 | -15.019 | 0 |
| Totaal overige inkomsten en kosten netto
| 2.043 | 1.005 | -0.24 | -1.817 | -38.973 | -23.545 | 24.986 | -0.617 | -0.65 | -1.886 | 2.088 | 1.214 | -0.912 | 0.041 | 1.36 |
| Inkomen voor belasting
| -25.42 | -19.512 | -19.97 | -23.501 | 25.846 | 11.673 | 46.545 | 34.567 | 16.577 | -16.175 | 14.682 | -6.384 | -31.031 | -24.235 | -35.341 |
| Inkomen voor belasting ratio
| 0 | -94.261 | 0 | -0.698 | 0.059 | 0.027 | 0.139 | 0.121 | 0.083 | -0.103 | 0.131 | -0.114 | -3.646 | -14.993 | 0 |
| Belastingkosten
| 4.327 | -3.802 | -3.748 | -4.474 | 6.008 | 0.515 | 13.877 | 9.03 | 4.309 | -4.817 | -21.131 | -1.214 | 0.912 | -0.041 | -1.36 |
| Nettowinst
| -21.093 | -15.71 | -16.222 | -19.027 | 19.838 | 11.158 | 32.668 | 25.537 | 12.268 | -11.358 | 35.813 | -6.384 | -31.031 | -24.235 | -35.341 |
| Nettowinstmarge
| 0 | -75.894 | 0 | -0.565 | 0.045 | 0.025 | 0.098 | 0.089 | 0.061 | -0.072 | 0.318 | -0.114 | -3.646 | -14.993 | 0 |
| WPA (Winst Per Aandeel)
| -1.33 | -1.38 | -2.43 | -6.51 | 6.39 | 5.47 | 19.38 | 15.37 | 8.2 | -8.61 | 32.87 | -7 | -43.37 | -75.99 | -126.11 |
| Verwaterde WPA
| -1.33 | -1.38 | -2.37 | -6.47 | 6.39 | 5.43 | 19.21 | 15.2 | 8.11 | -8.61 | 31.42 | -6.96 | -43.37 | -75.99 | -126.11 |
| EBITDA
| -26.959 | -16.859 | -17.257 | -19.148 | 94.331 | 73.587 | 37.293 | 46.238 | 25.962 | -7.786 | 15.68 | -5.892 | -29.809 | -24.06 | -35.202 |
| EBITDA ratio
| 0 | -81.444 | 0 | -0.569 | 0.215 | 0.168 | 0.112 | 0.162 | 0.13 | -0.049 | 0.139 | -0.105 | -3.502 | -14.886 | 0 |